As Valentine's Day approaches, the UConn School of Pharmacy wants to celebrate the chemistry we find in and out of our ...

Scientists are testing an experimental anti-amyloid antibody in people expected to develop early-onset Alzheimer's.

Scams involving celebrities or other famous people aren't really new - and are simply a modern take on the "Spanish Prisoner" or "Nigerian Prince" schemes ...

Eli Lilly’s profit doubled in the fourth quarter, propelled by its hot-selling diabetes and obesity treatments, and the drugmaker came out with a mostly better-than-expected 2025 forecast. Sales of ...

If Trump had withdrawn from NAFTA back then, Canada and the U.S. would just have reverted to most-favoured nation status with ...

Lilly (LLY) delivered earnings and revenue surprises of 5.77% and 0.44%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?

Brian Frank wants to run for Cincinnati mayor as a Republican. He champions outsourcing some services to save money and wants ...

Eli Lilly and Co. (LLY) on Thursday reported fourth-quarter earnings of $4.41 billion. The Indianapolis-based company said it had profit of $4.88 per share. Earnings, adjusted for one-time gains and ...

The increased popularity of football has contributed to the Super Bowl becoming the spectacle that it is today. Memorable, ...

US stocks rallied on Tuesday after President Donald Trump temporarily paused tariffs on Mexico and Canada, but not on China ...

The Washington University trial comes as part of a larger platform study which hopes to understand if Alzheimer's disease can ...

Novo Nordisk CEO Lars Fruergaard Jørgensen weighs in the company's latest obesity drug offering, including its new oral ...